WHITING PETROLEUM CORPORATION (a Delaware corporation) 5,750,000 Shares of Common Stock PURCHASE AGREEMENT
Exhibit 1.1
Execution Copy
XXXXXXX PETROLEUM CORPORATION
(a Delaware corporation)
5,750,000 Shares of Common Stock
(a Delaware corporation)
5,750,000 Shares of Common Stock
Dated: September 28, 2005
XXXXXXX PETROLEUM CORPORATION
(a Delaware corporation)
5,750,000 Shares of Common Stock
(Par Value $.001 Per Share)
PURCHASE AGREEMENT
(a Delaware corporation)
5,750,000 Shares of Common Stock
(Par Value $.001 Per Share)
PURCHASE AGREEMENT
September 28, 2005
XXXXXXX XXXXX & CO.
Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx
Incorporated
X.X. Xxxxxx Securities Inc.
Wachovia Capital Markets, LLC
as Representatives of the several Underwriters named in Schedule A hereto
Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx
Incorporated
X.X. Xxxxxx Securities Inc.
Wachovia Capital Markets, LLC
as Representatives of the several Underwriters named in Schedule A hereto
x/x | Xxxxxxx Xxxxx & Xx. Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated |
0 Xxxxx Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Xxx Xxxx, Xxx Xxxx 00000
c/o X.X. Xxxxxx Securities Inc.
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Ladies and Gentlemen:
Xxxxxxx Petroleum Corporation, a Delaware corporation (the “Company”) confirms its agreement
with Xxxxxxx Xxxxx & Co., Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated (“Xxxxxxx Xxxxx”),
X.X. Xxxxxx Securities Inc. (“JPMorgan”) and Wachovia Capital Markets, LLC (“Wachovia”) and each
of the other Underwriters named in Schedule A hereto (collectively, the “Underwriters”, which term
shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for
whom Xxxxxxx Xxxxx, JPMorgan and Wachovia are acting as representatives (in such capacity, the
“Representatives”), with respect to the issue and sale by the Company and the purchase by the
Underwriters, acting severally and not jointly, of the respective numbers of shares of Common
Stock, par value $.001 per share, of the Company (“Common Stock”) set forth in said Schedule A, and
with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of
the option described in Section 2(b) hereof to purchase all or any part of 862,500 additional
shares of Common Stock to cover overallotments, if any. The aforesaid 5,750,000 shares of Common
Stock (the “Initial Securities”) to be purchased by the Underwriters and all or any part of the
862,500 shares of Common Stock subject to the option described in Section 2(b) hereof (the “Option
Securities”) are hereinafter called, collectively, the “Securities.”
Concurrent with the offering and sale of the Securities by the Company pursuant to the terms
of this Agreement, the Company is offering to sell $250,000,000 in aggregate principal amount of
Senior Subordinated Notes due 2014 (the “Concurrent Offering”) pursuant to the
terms of a Purchase Agreement, dated of even date herewith, among the Company, Xxxxxxx Xxxxx,
JPMorgan and the other parties named therein. The offering, issuance and sale of the Securities by
the Company pursuant to the terms of this Agreement are not contingent on the successful completion
of the Concurrent Offering.
Prior to the date hereof, the Company, Xxxxxxx Oil and Gas Corporation (“Xxxxxxx Oil and Gas”)
and Celero Energy, LP, a Delaware limited partnership (“Celero”) entered into the Purchase and Sale
Agreement, dated effective as of July 1, 2005 (the “North Xxxx PSA”) with respect to the purchase
of certain oil and gas properties in Texas, Oklahoma and New Mexico.
The Company understands that the Underwriters propose to make a public offering of the
Securities as soon as the Representatives deem advisable after this Agreement has been executed and
delivered.
The Company has filed with the Securities and Exchange Commission (the “Commission”) a
registration statement on Form S-3 (Registration No. 333-121615), including the related prospectus,
for the registration of Common Stock and other securities of the Company (including the Securities)
under the Securities Act of 1933, as amended (the “1933 Act”), and the offering thereof from time
to time in accordance with Rule 415 of the rules and regulations of the Commission under the 1933
Act (the “1933 Act Regulations”). Such registration statement, including the Rule 462(b)
Registration Statement (as defined below), has been declared effective by the Commission. A
prospectus supplement reflecting the terms of the Securities, the terms of the offering thereof and
the other matters set forth therein has been prepared and will be filed pursuant to Rule 424 of the
1933 Act Regulations. Such prospectus supplement, in the form first filed after the date hereof
pursuant to Rule 424, is herein referred to as the “Prospectus Supplement.” Such registration
statement on Form S-3 (Registration No. 333-121615), as amended at the date hereof, including the
exhibits thereto, is herein called the “Registration Statement,” and the basic prospectus included
therein relating to all offerings of securities under the Registration Statement, as supplemented
by the Prospectus Supplement, is herein called the “Prospectus;” provided, however, that, if such
basic prospectus is amended or supplemented on or after the date hereof but prior to the date on
which the Prospectus Supplement is first filed pursuant to Rule 424, the term “Prospectus” shall
refer to the basic prospectus as so amended or supplemented and as supplemented by the Prospectus
Supplement; and provided, further, that all references to the “Registration Statement” and the
“Prospectus” shall be deemed to include all documents incorporated therein by reference pursuant to
the Securities Exchange Act of 1934, as amended (the “1934 Act”); and provided, further, that all
references to the “Registration Statement” shall also be deemed to include the registration
statement filed with the Commission on September 19, 2005 pursuant to Rule 462(b) of the 1933 Act
Regulations (the “Rule 462(b) Registration Statement”). For purposes of this Agreement, all
references to the Registration Statement, Prospectus, Prospectus Supplement or preliminary
prospectus or to any amendment or supplement to any of the foregoing shall be deemed to include any
copy filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval
system (“XXXXX”).
All references in this Agreement to financial statements and schedules and other information
that is “described,” “contained,” “included” or “stated” in the Registration Statement, any
preliminary prospectus or the Prospectus (or other references of like import) shall
2
be deemed to mean and include all such financial statements and schedules and other
information that is incorporated by reference in the Registration Statement, any preliminary
prospectus or the Prospectus, as the case may be; and all references in this Agreement to
amendments or supplements to the Registration Statement, any preliminary prospectus or the
Prospectus shall be deemed to mean and include the filing of any document under the 1934 Act that
is incorporated by reference in the Registration Statement, such preliminary prospectus or the
Prospectus, as the case may be.
SECTION 1. Representations and Warranties.
(a) Representations and Warranties by the Company. The Company represents and
warrants to each Underwriter as of the date hereof, as of the Closing Time referred to in Section
2(c) hereof, and as of each Date of Delivery (if any) referred to in Section 2(b) hereof, and agree
with each Underwriter, as follows:
(i) Compliance with Registration Requirements. The Company meets the
requirements for use of Form S-3 under the 1933 Act. Each of the Registration Statement,
the Rule 462(b) Registration Statement and any post-effective amendment thereto has become
effective under the 1933 Act and no stop order suspending the effectiveness of the
Registration Statement, the Rule 462(b) Registration Statement or any post-effective
amendment thereto has been issued under the 1933 Act and no proceedings for that purpose
have been instituted or are pending or, to the knowledge of the Company, are contemplated by
the Commission, and any request on the part of the Commission for additional information has
been complied with.
At the respective times the Registration Statement, the Rule 462(b) Registration
Statement and any post-effective amendments thereto became effective and at the Closing Time
(and, if any Option Securities are purchased, at the Date of Delivery), the Registration
Statement, the Rule 462(b) Registration Statement and any amendments and supplements thereto
complied and will comply in all material respects with the requirements of the 1933 Act and
the 1933 Act Regulations and did not and will not contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein not misleading. Neither the Prospectus nor any amendments or supplements
thereto, at the time the Prospectus or any such amendment or supplement was issued and at
the Closing Time (and, if any Option Securities are purchased, at the Date of Delivery),
included or will include an untrue statement of a material fact or omitted or will omit to
state a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The representations and
warranties in this paragraph shall not apply to statements in or omissions from the
Registration Statement or Prospectus or any amendment or supplement thereto made in reliance
upon and in conformity with written information furnished to the Company by any Underwriter
through Xxxxxxx Xxxxx expressly for use in the Registration Statement (or any amendment
thereto) or the Prospectus (or any amendment or supplement thereto).
Each preliminary prospectus and the prospectus filed as part of the Registration
Statement as originally filed or as part of any amendment thereto complied when so filed
3
in all material respects with the 1933 Act Regulations and each preliminary prospectus
and the Prospectus to be delivered to the Underwriters for use in connection with this
offering will be identical to the electronically transmitted copies thereof filed with the
Commission pursuant to XXXXX, except to the extent permitted by Regulation S-T.
(ii) Incorporated Documents. The documents incorporated or deemed to be
incorporated by reference in the Registration Statement and the Prospectus, at the time they
were or hereafter are filed with the Commission, complied and will comply in all material
respects with the requirements of the 1934 Act and the rules and regulations of the
Commission thereunder (the “1934 Act Regulations”), and, when read together with the other
information in the Prospectus, at the time the Registration Statement became effective, at
the time the Prospectus is issued and at the Closing Time, did not and will not contain an
untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading.
(iii) Independent Accountants. The accountants who certified the financial
statements and supporting schedules included in the Registration Statement are independent
public accountants with respect to the Company as required by the 1933 Act and the 1933 Act
Regulations.
(iv) Financial Statements. The financial statements included in the
Registration Statement and the Prospectus, together with the related schedules and notes,
present fairly in all material respects, on the basis set forth in the Prospectus, the
financial position of the Company and its consolidated subsidiaries at the dates indicated
and the statement of income, stockholders’ equity and cash flows of Company and its
consolidated subsidiaries for the periods specified; said financial statements have been
prepared in conformity with generally accepted accounting principles in the United States
(“GAAP”) applied on a consistent basis throughout the periods involved. The supporting
schedules, if any, included in the Registration Statement present fairly in all material
respects in accordance with GAAP the information required to be stated therein. The summary
financial information included in the Prospectus present fairly in all material respects the
information shown therein and have been compiled on a basis consistent with that of the
audited financial statements included in the Registration Statement. The summary pro forma
financial information, the pro forma financial statements and the related notes thereto
included in the Registration Statement and the Prospectus present fairly in all material
respects, on the basis set forth in the Prospectus, the information shown therein, have been
prepared in all material respects in accordance with the Commission’s rules with respect to
pro forma financial statements and have been properly compiled on the bases described
therein, and the assumptions used in the preparation thereof are reasonable and are set
forth in the Prospectus and the adjustments used therein are appropriate in all material
respects to give effect to the transactions and circumstances referred to therein.
All disclosures contained in the Registration Statement or the Prospectus regarding
“non-GAAP financial measures” (as such term is defined by the rules and regulations of the
Commission) comply in all material respects with Regulation G of the Exchange Act and Item
10 of Regulation S-K under the Act, to the extent applicable.
4
(v) No Material Adverse Change in Business. Since the respective dates as of
which information is given in the Registration Statement and the Prospectus, except as
otherwise stated therein, (A) there has been no material adverse change in the condition,
financial or otherwise, or in the earnings, business affairs or business prospects of the
Company and its subsidiaries considered as one enterprise, whether or not arising in the
ordinary course of business (a “Material Adverse Effect”), (B) there have been no
transactions entered into by the Company or any of its subsidiaries, other than those in the
ordinary course of business, which are material with respect to the Company and its
subsidiaries considered as one enterprise, and (C) except as described in the Prospectus,
there has been no dividend or distribution of any kind declared, paid or made by the Company
on any class of its capital stock.
(vi) Good Standing of the Company. The Company has been duly organized and is
validly existing as a corporation in good standing under the laws of the State of Delaware
and has corporate power and authority to own, lease and operate its properties and to
conduct its business as described in the Prospectus and to enter into and perform its
obligations under this Agreement; and the Company is duly qualified as a foreign corporation
to transact business and is in good standing in each other jurisdiction in which such
qualification is required, whether by reason of the ownership or leasing of property or the
conduct of business, except where the failure so to qualify or to be in good standing would
not result in a Material Adverse Effect.
(vii) Good Standing of Subsidiaries. Each of Xxxxxxx Oil and Gas, Xxxxxxx
Programs, Inc. and Equity Oil Company (each a “Subsidiary” and, collectively, the
“Subsidiaries”) has been duly organized and is validly existing as a corporation in good
standing under the laws of the jurisdiction of its incorporation, has corporate power and
authority to own, lease and operate its properties and to conduct its business as described
in the Prospectus and is duly qualified as a foreign corporation to transact business and is
in good standing in each jurisdiction in which such qualification is required, whether by
reason of the ownership or leasing of property or the conduct of business, except where the
failure so to qualify or to be in good standing would not result in a Material Adverse
Effect; except as otherwise disclosed in the Registration Statement, all of the issued and
outstanding capital stock of each such Subsidiary has been duly authorized and validly
issued, is fully paid and non-assessable and is owned by the Company, directly or through
subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance,
claim or equity; none of the outstanding shares of capital stock of any Subsidiary was
issued in violation of the preemptive or similar rights of any securityholder of such
Subsidiary. As of the date of this Agreement, the only subsidiaries of the Company are the
Subsidiaries, Xxxxxxx Transpetco LP, LLC and Xxxxxxx Transpetco GP, LLC. The subsidiaries
of the Company, other than the Subsidiaries, considered in the aggregate as a single
subsidiary, do not constitute a “significant subsidiary” as defined in Rule 1-02 of
Regulation S-X.
(viii) Capitalization. The authorized, issued and outstanding capital stock of
the Company is as set forth in the Prospectus in the column entitled “Actual” under the
caption “Capitalization” (except for subsequent issuances, if any, pursuant to reservations,
agreements or employee benefit plans referred to in the Prospectus or
5
pursuant to the North Xxxx PSA). The shares of issued and outstanding capital stock of
the Company have been duly authorized and validly issued and are fully paid and
non-assessable; none of the outstanding shares of capital stock of the Company was issued in
violation of the preemptive or other similar rights of any securityholder of the Company.
(ix) Authorization and Enforceability of Agreements. This Agreement has been
duly authorized, executed and delivered by the Company. The North Xxxx PSA has been duly
authorized, executed and delivered by the Company and Xxxxxxx Oil and Gas, as applicable,
and is a valid and legally binding agreement of the Company and Xxxxxxx Oil and Gas, as
applicable, enforceable against each of them, as applicable, in accordance with its terms,
except as the enforcement thereof may be limited by bankruptcy, insolvency (including,
without limitation, all laws relating to fraudulent transfers), reorganization, moratorium
or similar laws affecting enforcement of creditors’ rights generally and except as
enforcement thereof is subject to general principles of equity (regardless of whether
enforcement is considered in a proceeding in equity or at law).
(x) Authorization and Description of Securities. The Securities to be
purchased by the Underwriters from the Company have been duly authorized for issuance and
sale to the Underwriters pursuant to this Agreement, and, when issued and delivered by the
Company pursuant to this Agreement against payment of the consideration set forth herein,
will be validly issued, fully paid and non-assessable; the Common Stock conforms in all
material respects to all statements relating thereto contained in the Prospectus and such
description conforms in all material respects to the rights set forth in the instruments
defining the same; no holder of the Securities will be subject to personal liability by
reason of being such a holder; and the Securities are not subject to the preemptive or other
similar rights of any securityholder of the Company.
(xi) Absence of Defaults and Conflicts. Neither the Company nor any of its
subsidiaries is in violation of its respective charter or by-laws or in default in the
performance or observance of any obligation, agreement, covenant or condition contained in
any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or
other agreement or instrument to which the Company or any of its subsidiaries is a party or
by which it or any of them may be bound, or to which any of the property or assets of the
Company or any of its subsidiaries is subject (collectively, “Agreements and Instruments”),
except for such violations or defaults that would not result in a Material Adverse Effect;
and the execution, delivery and performance of this Agreement and the North Xxxx PSA and the
consummation of the transactions contemplated herein and therein and in the Registration
Statement (including the offering, issuance and sale of the Securities pursuant to this
Agreement and the use of the proceeds to the Company from the sale of the Securities as
described in the Prospectus under the caption “Use of Proceeds”) and compliance by the
Company and Xxxxxxx Oil and Gas with their respective obligations hereunder and thereunder
have been duly authorized by all necessary corporate action and do not and will not, whether
with or without the giving of notice or passage of time or both, conflict with or constitute
a breach of, or default or Repayment Event (as defined below) under, or result in the
creation or imposition of any lien, charge or encumbrance upon any property or assets of the
Company or any of its
6
subsidiaries pursuant to, the Agreements and Instruments (except for such conflicts,
breaches, defaults or Repayment Events or liens, charges or encumbrances that would not
result in a Material Adverse Effect), nor will such action result in any violation of the
provisions of the charter or by-laws of the Company or any of its subsidiaries or any
applicable law, statute, rule, regulation, judgment, order, writ or decree of any
government, government instrumentality or court, domestic or foreign, having jurisdiction
over the Company or any of its subsidiaries or any of their assets, properties or operations
(except for such violations that would not result in a Material Adverse Effect). As used
herein, a “Repayment Event” means any event or condition which gives the holder of any note,
debenture or other evidence of indebtedness (or any person acting on such holder’s behalf)
the right to require the repurchase, redemption or repayment of all or a portion of such
indebtedness by the Company or any of its subsidiaries.
(xii) Absence of Labor Dispute. No labor dispute with the employees of the
Company or any subsidiary of the Company exists or, to the knowledge of the Company, is
imminent, and the Company is not aware of any existing or imminent labor disturbance by the
employees of any of their or any subsidiary’s principal suppliers, manufacturers, customers
or contractors, which, in either case, would reasonably be expected to result in a Material
Adverse Effect.
(xiii) Absence of Proceedings. There is no action, suit, proceeding, inquiry
or investigation before or brought by any court or governmental agency or body, domestic or
foreign, now pending, or, to the knowledge of the Company, threatened, against or affecting
the Company or any subsidiary of the Company, which is required to be disclosed in the
Registration Statement (other than as disclosed therein), or which might reasonably be
expected to result in a Material Adverse Effect, or which might reasonably be expected to
materially and adversely affect the properties or assets thereof or the consummation of the
transactions contemplated in this Agreement or the North Xxxx PSA or the performance by the
Company or Xxxxxxx Oil and Gas of their respective obligations hereunder or thereunder. The
aggregate of all pending legal or governmental proceedings to which the Company or any
subsidiary of the Company is a party or of which any of their respective property or assets
is the subject which are not described in the Registration Statement, including ordinary
routine litigation incidental to the business, could not reasonably be expected to result in
a Material Adverse Effect.
(xiv) Accuracy of Exhibits. There are no contracts or documents which are
required to be described in the Registration Statement, the Prospectus or the documents
incorporated by reference therein or to be filed as exhibits thereto which have not been so
described and filed as required.
(xv) Possession of Intellectual Property. The Company and its subsidiaries own
or possess, or can acquire on reasonable terms, adequate patents, patent rights, licenses,
inventions, copyrights, know-how (including trade secrets and other unpatented and/or
unpatentable proprietary or confidential information, systems or procedures), trademarks,
service marks, trade names or other intellectual property (collectively, “Intellectual
Property”) necessary to carry on the business now operated by them, and neither the Company
nor any of its subsidiaries has received any written notice or is
7
otherwise aware of any infringement of or conflict with asserted rights of others with
respect to any Intellectual Property or of any facts or circumstances which would render any
Intellectual Property invalid or inadequate to protect the interest of the Company or any
of its subsidiaries therein, and which infringement or conflict (if the subject of any
unfavorable decision, ruling or finding) or invalidity or inadequacy, singly or in the
aggregate, would result in a Material Adverse Effect.
(xvi) Absence of Further Requirements. No filing with, or authorization,
approval, consent, license, order, registration, qualification or decree of, any court or
governmental authority or agency is necessary or required for the performance by the Company
of its obligations hereunder, in connection with the offering, issuance or sale by the
Company of the Securities hereunder or the consummation of the transactions contemplated by
this Agreement or the North Xxxx PSA, except such as have been already obtained or made or
as may be required under the 1933 Act or the 1933 Act Regulations or state securities laws
and, in the case of the North Xxxx PSA, except such as (A)(i) are of a routine or
administrative nature, (ii) are not customarily obtained or made prior to the consummation
of transactions such as those contemplated by the North Xxxx PSA, and (iii) are expected in
the reasonable judgment of the Company to be obtained in the ordinary course of business
subsequent to the consummation of the transactions contemplated by the North Xxxx PSA, or
(B) if not obtained, would not, individually or in the aggregate, have a Material Adverse
Effect.
(xvii) Absence of Manipulation. Neither the Company nor any affiliate of the
Company has taken, nor will the Company or any affiliate take, directly or indirectly, any
action which is designed to or which has constituted or which would be expected to cause or
result in stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Securities.
(xviii) Possession of Licenses and Permits. The Company and its subsidiaries
possess such permits, licenses, approvals, consents and other authorizations (collectively,
“Governmental Licenses”) issued by the appropriate federal, state, local or foreign
regulatory agencies or bodies necessary to conduct the business now operated by them, except
where the failure so to possess would not, singly or in the aggregate, result in a Material
Adverse Effect; the Company and its subsidiaries are in compliance with the terms and
conditions of all such Governmental Licenses, except where the failure so to comply would
not, singly or in the aggregate, result in a Material Adverse Effect; all of the
Governmental Licenses are valid and in full force and effect, except when the invalidity of
such Governmental Licenses or the failure of such Governmental Licenses to be in full force
and effect would not, singly or in the aggregate, result in a Material Adverse Effect; and
neither the Company nor any of its subsidiaries has received any written notice of
proceedings relating to the revocation or modification of any such Governmental Licenses
which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or
finding, would result in a Material Adverse Effect.
(xix) Title to Property. The Company and its subsidiaries have good and
marketable title to all real property owned by the Company and its subsidiaries, including,
without limitation, all oil and gas producing properties, and good title to all
8
other properties owned by them, including, without limitation, all assets and
facilities used by the Company and its subsidiaries in the production and marketing of oil
and gas, in each case, free and clear of all mortgages, pledges, liens, security interests,
claims, restrictions or encumbrances of any kind except such as (a) are described in the
Prospectus or (b) do not, singly or in the aggregate, materially affect the value of such
property and do not interfere with the use made and proposed to be made of such property by
the Company or any of its subsidiaries; and all of the leases and subleases material to the
business of the Company and its subsidiaries, considered as one enterprise, and under which
the Company or any of its subsidiaries holds properties described in the Prospectus,
including, without limitation, all oil and gas producing properties of the Company and its
subsidiaries and all assets and facilities used by the Company and its subsidiaries in the
production and marketing of oil and gas, are in full force and effect, except where such
would not have a Material Adverse Effect, and neither the Company nor any of its
subsidiaries has any written notice of any material claim of any sort that has been asserted
by anyone adverse to the rights of the Company or any of its subsidiaries under any of the
leases or subleases mentioned above, or affecting or questioning the rights of the Company
or such subsidiary to the continued possession of the leased or subleased premises under any
such lease or sublease, except where such would not have a Material Adverse Effect.
(xx) Environmental Laws. Except as described in the Registration Statement and
except as would not, singly or in the aggregate, result in a Material Adverse Effect, (A)
neither the Company nor any of its subsidiaries is in violation of any federal, state, local
or foreign statute, law, rule, regulation, ordinance, code, policy or rule of common law or
any judicial or administrative interpretation thereof, including any judicial or
administrative order, consent, decree or judgment, relating to pollution or protection of
human health, the environment (including, without limitation, ambient air, surface water,
groundwater, land surface or subsurface strata) or wildlife, including, without limitation,
laws and regulations relating to the release or threatened release of chemicals, pollutants,
contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum
products, asbestos-containing materials or mold (collectively, “Hazardous Materials”) or to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or
handling of Hazardous Materials (collectively, “Environmental Laws”), (B) the Company and
its subsidiaries have all permits, authorizations and approvals required under any
applicable Environmental Laws and are each in compliance with their requirements, (C) there
are no pending or, to the knowledge of the Company, threatened administrative, regulatory or
judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or
violation, investigation or proceedings relating to any Environmental Law against the
Company or any of its subsidiaries and (D) there are no events or circumstances that would
reasonably be expected to form the basis of an order for clean-up or remediation, or an
action, suit or proceeding by any private party or governmental body or agency, against or
affecting the Company or any of its subsidiaries relating to Hazardous Materials or any
Environmental Laws.
9
(xxi) Registration Rights. Other than persons granted registration rights
pursuant to the registration rights agreement to be entered into in connection with the
Concurrent Offering (the “Registration Rights Agreement”), there are no persons with
registration rights or other similar rights to have any securities registered pursuant to
the Registration Statement, except pursuant to the North Xxxx PSA, or otherwise registered
by the Company under the 1933 Act.
(xxii) Independent Petroleum Engineers. Xxxxxx, Xxxxxxxxx & Associates, Inc.,
whose report as of January 1, 2005 is referenced in the Prospectus, was, as of the date of
such report, and is, as of the date hereof, an independent petroleum engineer with respect
to the Company and its subsidiaries. X.X. Xxxxxx & Associates, Inc., whose report as of
January 1, 2005 is referenced in the Prospectus, was, as of the date of such report, and is,
as of the date hereof, an independent petroleum engineer with respect to the Company and its
subsidiaries. Xxxxx Xxxxx Company, L.P., whose report as of January 1, 2005 is referenced
in the Prospectus, was, as of the date of such report, and is, as of the date hereof, an
independent petroleum engineer with respect to the Company and its subsidiaries.
Netherland, Xxxxxx and Associates, Inc., whose report as of July 1, 2005 is referenced in
the Prospectus, was, as of the date of such report, an independent petroleum engineer with
respect to the Company and, to the Company’s knowledge, with respect to Celero and its
subsidiaries.
(xxiii) Accuracy of Reserve Information. The information underlying the
estimates of reserves of the Company and its subsidiaries, which was supplied by the Company
to Xxxxxx, Xxxxxxxxx & Associates, Inc., X.X. Xxxxxx & Associates, Inc. and Xxxxx Xxxxx
Company, L.P. for purposes of auditing the reserve reports and estimates of the Company and
preparing the respective letters (the “Reserve Report Letters” and each a “Reserve Report
Letter”) of each of Xxxxxx, Xxxxxxxxx & Associates, Inc., X.X. Xxxxxx & Associates, Inc. and
Xxxxx Xxxxx Company, L.P., including, without limitation, production, costs of operation and
development, current prices for production, agreements relating to current and future
operations and sales of production, was true and correct in all material respects on the
dates such estimates were made and such information was supplied and was prepared in
accordance with customary industry practices; other than normal production of the reserves
and intervening spot market product price fluctuations described in the Prospectus, neither
the Company nor its subsidiaries is aware of any facts or circumstances that would result in
an adverse change in the reserves, or the present value of future net cash flows therefrom,
as described in the Prospectus and as reflected in each Reserve Report Letter, that would
reasonably be expected to result in a Material Adverse Effect; estimates of such reserves
and present values as described in the Prospectus and reflected in each Reserve Report
Letter comply in all material respects with the applicable requirements of Regulation S-X
and Industry Guide 2 under the 1933 Act.
(xxiv) Oil and Gas Agreements. The participation agreements, joint development
agreements, joint operating agreements, farm-out agreements and other agreements described
in the Prospectus relating to the Company or its subsidiaries’ rights with respect to the
ownership, lease or operation of oil and gas properties, the acquisition of interests in oil
and gas properties or the exploration for, development of or production of oil and gas
reserves thereon, constitute valid and binding agreements of the Company and its
subsidiaries that are parties thereto and, to the best knowledge of the Company, of
10
the other parties thereto, enforceable in accordance with their terms, except as the
enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation,
all laws relating to fraudulent transfers), reorganization, moratorium or similar laws
affecting enforcement of creditors’ rights generally and except as enforcement thereof is
subject to general principles of equity (regardless of whether enforcement is considered in
a proceeding in equity or at law).
(xxv) Insurance. The Company and each of its subsidiaries maintain insurance
covering their properties, operations, personnel and businesses that, in the Company’s
reasonable judgment, insures against such losses and risks as are adequate in accordance
with customary industry practices to protect the Company and its subsidiaries and their
businesses.
(xxvi) Accounting Controls and Disclosure Controls. (A) The Company and each
of its subsidiaries maintain a system of internal accounting controls sufficient to provide
reasonable assurances that (1) transactions are executed in accordance with management’s
general or specific authorization; (2) transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to maintain accountability
for assets; (3) access to assets is permitted only in accordance with management’s general
or specific authorization; and (4) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. Except as described in the Prospectus, since the end of the Company’s most
recent audited fiscal year, there has been (I) no material weakness in the Company’s
internal control over financial reporting (whether or not remediated) and (II) no change in
the Company’s internal control over financial reporting that has materially affected, or is
reasonably likely to materially affect, the Company’s internal control over financial
reporting.
(xxvii) (B) The Company maintains disclosure controls and procedures that are
designed to ensure that information required to be disclosed by the Company in the reports
that it files or submits under the 1934 Act is recorded, processed, summarized and reported,
within the time periods specified in the Commission’s rules and forms, and is accumulated
and communicated to the Company’s management, including its principal executive officer or
officers and principal financial officer or officers, as appropriate, to allow timely
decisions regarding disclosure.
(b) Officer’s Certificates. Any certificate signed by any officer of the Company or any
of its subsidiaries delivered to the Representatives or to counsel for the Underwriters shall be
deemed a representation and warranty by the Company to each Underwriter as to the matters covered
thereby.
SECTION 2. Sale and Delivery to Underwriters; Closing.
(a) Initial Securities. On the basis of the representations and warranties herein
contained and subject to the terms and conditions herein set forth, the Company agrees to sell to
each Underwriter, and each Underwriter, severally and not jointly, agrees to purchase from the
Company, at the price per share set forth in Schedule B, the number of Initial Securities set forth
in Schedule A opposite the name of such Underwriter, plus any additional number of Initial
Securities which such Underwriter may become obligated to purchase pursuant to the provisions
of Section 10 hereof.
11
(b) Option Securities. In addition, on the basis of the representations and
warranties herein contained and subject to the terms and conditions herein set forth, the Company
hereby grants an option to the Underwriters, severally and not jointly, to purchase up to an
additional 862,500 shares of Common Stock from the Company at the price per share set forth in
Schedule B, less an amount per share equal to any dividends or distributions declared by the
Company and payable on the Initial Securities but not payable on the Option Securities. The option
hereby granted will expire 30 days after the date hereof and may be exercised in whole or in part
from time to time only for the purpose of covering overallotments which may be made in connection
with the offering and distribution of the Initial Securities upon notice by the Representatives to
the Company setting forth the number of Option Securities as to which the several Underwriters are
then exercising the option and the time and date of payment and delivery for such Option
Securities. Any such time and date of delivery (a “Date of Delivery”) shall be determined by the
Representatives, but shall not be later than seven full business days after the exercise of said
option, nor in any event prior to the Closing Time, as hereinafter defined. If the option is
exercised as to all or any portion of the Option Securities, each of the Underwriters, acting
severally and not jointly, will purchase that proportion of the total number of Option Securities
then being purchased which the number of Initial Securities set forth in Schedule A opposite the
name of such Underwriter bears to the total number of Initial Securities, subject in each case to
such adjustments as the Representatives in their discretion shall make to eliminate any sales or
purchases of fractional shares.
(c) Payment. Payment of the purchase price for, and delivery of certificates for,
the Initial Securities shall be made via facsimile and email and at the office of Xxxxxxx Petroleum
Corporation, 0000 Xxxxxxxx, Xxxxx 0000, Xxxxxx, Xxxxxxxx 00000-0000, or at such other place as
shall be agreed upon by the Representatives and the Company, at 9:00 A.M. (Eastern time) on the
third (fourth, if the pricing occurs after 4:30 P.M. (Eastern time) on any given day) business day
after the date hereof (unless postponed in accordance with the provisions of Section 10), or such
other time not later than ten business days after such date as shall be agreed upon by the
Representatives and the Company (such time and date of payment and delivery being herein called
“Closing Time”).
In addition, in the event that any or all of the Option Securities are purchased by the
Underwriters, payment of the purchase price for, and delivery of certificates for, such Option
Securities shall be made at the above-mentioned offices, or at such other place as shall be agreed
upon by the Representatives and the Company, on each Date of Delivery as specified in the notice
from the Representatives to the Company.
Payment shall be made to the Company by wire transfer of immediately available funds to a bank
account designated by the Company, against delivery to Xxxxxxx Xxxxx for the respective accounts of
the Underwriters of certificates for the Securities to be purchased by them. It is understood that
each Underwriter has authorized Xxxxxxx Xxxxx, for its account, to accept delivery of, receipt for,
and make payment of the purchase price for, the Initial Securities and the Option Securities, if
any, which it has agreed to purchase. Xxxxxxx Xxxxx, individually and not as representative of the
Underwriters, may (but shall not be obligated to) make payment of the
12
purchase price for the Initial Securities or the Option Securities, if any, to be purchased by
any Underwriter whose funds have not been received by the Closing Time or the relevant Date of
Delivery, as the case may be, but such payment shall not relieve such Underwriter from its
obligations hereunder.
(d) Denominations; Registration. Certificates for the Initial Securities and the
Option Securities, if any, shall be in such denominations and registered in such names as Xxxxxxx
Xxxxx may request in writing at least one full business day before the Closing Time or the relevant
Date of Delivery, as the case may be. The Company will deliver the Initial Securities, and the
Company shall deliver the Option Securities, if any, to Xxxxxxx Xxxxx for the accounts of the
Underwriters through the facilities of the Depositary Trust Company (“DTC”), against payment of the
purchase price in federal (same day) funds by official bank check or checks or wire transfer to an
account for the Company at a bank reasonably acceptable to Xxxxxxx Xxxxx drawn to the order of the
Company prior to the Closing Time or the relevant Date of Delivery, as the case may be.
SECTION 3. Covenants of the Company. The Company covenants with each
Underwriter as follows:
(a) Compliance with Securities Regulations and Commission Requests. The Company,
subject to Section 3(b), will comply with the requirements of Rule 430A and will notify the
Representatives immediately, and confirm the notice in writing, (i) when any post-effective
amendment to the Registration Statement shall become effective, or any supplement to the Prospectus
or any amended Prospectus shall have been filed, (ii) of the receipt of any comments from the
Commission with respect to the Registration Statement, (iii) of any request by the Commission for
any amendment to the Registration Statement or any amendment or supplement to the Prospectus or any
document incorporated by reference therein or for additional information, and (iv) of the issuance
by the Commission of any stop order suspending the effectiveness of the Registration Statement or
of any order preventing or suspending the use of any preliminary prospectus, or of the suspension
of the qualification of the Securities for offering or sale in any jurisdiction, or of the
initiation or threatening of any proceedings for any of such purposes. The Company will promptly
effect the filings necessary pursuant to Rule 424(b) and will take such steps as it deems necessary
to ascertain promptly whether the form of prospectus transmitted for filing under Rule 424(b) was
received for filing by the Commission and, in the event that it was not, it will promptly file such
prospectus. The Company will make every reasonable effort to prevent the issuance of any stop
order and, if any stop order is issued, to obtain the lifting thereof at the earliest possible
moment.
(b) Filing of Amendments. The Company will give the Representatives notice of its
intention to file or prepare any amendment to the Registration Statement (including any filing
under Rule 462(b)) or any amendment, supplement or revision to either the prospectus included in
the Registration Statement at the time it became effective or to the Prospectus, whether pursuant
to the 1933 Act, the 1934 Act or otherwise, and will furnish the Representatives with copies of any
such documents a reasonable amount of time prior to such proposed filing or use, as the case may
be, and will not file or use any such document to which the Representatives or counsel for the
Underwriters shall reasonably object.
13
(c) Delivery of Registration Statements. The Company has furnished or will deliver
to the Representatives and counsel for the Underwriters, without charge, copies (one of which shall
be manually signed) of the Registration Statement as originally filed and of each amendment thereto
(including exhibits filed therewith or incorporated by reference therein) and copies (one of which
shall be manually signed) of all consents and certificates of experts, and will also deliver to the
Representatives, without charge, a conformed copy of the Registration Statement as originally filed
and of each amendment thereto (without exhibits) for each of the Underwriters. The copies of the
Registration Statement and each amendment thereto furnished to the Underwriters will be identical
to the electronically transmitted copies thereof filed with the Commission pursuant to XXXXX,
except to the extent permitted by Regulation S-T.
(d) Delivery of Prospectuses. The Company has delivered to each Underwriter,
without charge, as many copies of each preliminary prospectus as such Underwriter reasonably
requested, and the Company hereby consents to the use of such copies for purposes permitted by the
1933 Act. The Company will furnish to each Underwriter, without charge, during the period when the
Prospectus is required to be delivered under the 1933 Act, such number of copies of the Prospectus
(as amended or supplemented) as such Underwriter may reasonably request. The Prospectus and any
amendments or supplements thereto furnished to the Underwriters will be identical to the
electronically transmitted copies thereof filed with the Commission pursuant to XXXXX, except to
the extent permitted by Regulation S-T.
(e) Continued Compliance with Securities Laws. The Company will comply with the
1933 Act and the 1933 Act Regulations and the 1934 Act and the 1934 Act Regulations so as to permit
the completion of the distribution of the Securities as contemplated in this Agreement and in the
Prospectus. If at any time when a prospectus is required by the 1933 Act to be delivered in
connection with sales of the Securities, any event shall occur or condition shall exist as a result
of which it is necessary, in the reasonable opinion of counsel for the Underwriters or for the
Company, to amend the Registration Statement or amend or supplement the Prospectus in order that
the Prospectus will not include any untrue statements of a material fact or omit to state a
material fact necessary in order to make the statements therein not misleading in the light of the
circumstances existing at the time it is delivered to a purchaser, or if it shall be necessary, in
the reasonable opinion of such counsel, at any such time to amend the Registration Statement or
amend or supplement the Prospectus in order to comply with the requirements of the 1933 Act or the
1933 Act Regulations, the Company will promptly prepare and file with the Commission, subject to
Section 3(b), such amendment or supplement as may be necessary to correct such statement or
omission or to make the Registration Statement or the Prospectus comply with such requirements, and
the Company will furnish to the Underwriters such number of copies of such amendment or supplement
as the Underwriters may reasonably request.
(f) Blue Sky Qualifications. The Company will use its best efforts, in cooperation
with the Underwriters, to qualify the Securities for offering and sale under the applicable
securities laws of such states and other jurisdictions (domestic or foreign) as the Representatives
may designate and to maintain such qualifications in effect for a period of not less than one year
from the later of the effective date of the Registration Statement and the Rule 462(b) Registration
Statement; provided, however, that the Company shall not be obligated to file any general consent
to service of process or to qualify as a foreign corporation or as a dealer in securities in
any jurisdiction in which it is not so qualified or to subject itself to taxation in respect
of doing business in any jurisdiction in which it is not otherwise so subject.
14
(g) Rule 158. The Company will timely file such reports pursuant to the Securities
Exchange Act of 1934, as amended (the “1934 Act”), as are necessary in order to make generally
available to its securityholders as soon as practicable an earnings statement for the purposes of,
and to provide the benefits contemplated by, the last paragraph of Section 11(a) of the 1933 Act.
(h) Use of Proceeds. The Company will use the net proceeds received by it from the
sale of the Securities in the manner specified in the Prospectus under “Use of Proceeds.”
(i) Listing. The Company will use its best efforts to effect the listing of the
Securities on the New York Stock Exchange.
(j) Restriction on Sale of Securities. During a period of 90 days from the date of
the Prospectus, the Company will not, without the prior written consent of Xxxxxxx Xxxxx and
JPMorgan, (i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option, right or warrant
to purchase or otherwise transfer or dispose of any share of Common Stock or any securities
convertible into or exercisable or exchangeable for Common Stock or file any registration statement
under the 1933 Act with respect to any of the foregoing or (ii) enter into any swap or any other
agreement or any transaction that transfers, in whole or in part, directly or indirectly, the
economic consequence of ownership of the Common Stock, whether any such swap or transaction
described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other
securities, in cash or otherwise. The foregoing sentence shall not apply to (A) the Securities to
be sold hereunder, (B) any shares of Common Stock issued by the Company upon the exercise of an
option or warrant or the conversion of a security outstanding on the date hereof and referred to in
the Prospectus, (C) any shares of Common Stock issued or options to purchase Common Stock granted
pursuant to existing employee benefit plans of the Company referred to in the Prospectus, (D) any
registration statement with respect to shares of Common Stock to be issued and sold by the Company
and (E) 441,500 shares of Common Stock to be issued to Celero pursuant to the North Xxxx PSA.
Notwithstanding the foregoing, if (1) during the last 17 days of the 90-day restricted period the
Company issues an earnings release or material news or a material event relating to the Company
occurs or (2) prior to the expiration of the 90-day restricted period, the Company announces that
it will release earnings results or becomes aware that material news or a material event will occur
during the 16-day period beginning on the last day of the 90-day restricted period, the
restrictions imposed in this clause (j) shall continue to apply until the expiration of the 18-day
period beginning on the issuance of the earnings release or the occurrence of the material news or
material event, as applicable, unless Xxxxxxx Xxxxx and JPMorgan waive, in writing, such extension.
(k) Reporting Requirements. The Company, during the period when the Prospectus is
required to be delivered under the 1933 Act, will file all documents required to be filed with the
Commission pursuant to the 1934 Act within the time periods required by the 1934 Act and the 1934
Act Regulations.
15
(l) No Advisory or Fiduciary Relationship. The Company acknowledges and
agrees that (i) the purchase and sale of the Securities pursuant to this Agreement, including the
determination of the public offering price of the Securities and any related discounts and
commissions, is an arm’s-length commercial transaction between the Company, on the one hand, and
the several Underwriters, on the other hand, (ii) in connection with the offering contemplated
hereby and the process leading to such transaction each Underwriter is and has been acting solely
as a principal and is not the agent or fiduciary of the Company or its stockholders, creditors,
employees or any other party, (iii) no Underwriter has assumed or will assume an advisory or
fiduciary responsibility in favor of the Company with respect to the offering contemplated
hereby or the process leading thereto (irrespective of whether such Underwriter has
advised or is currently advising the Company on other matters) and no Underwriter has any
obligation to the Company with respect to the offering contemplated hereby (other than any
confidentiality obligation that such Underwriter may generally have to the Company) except the
obligations expressly set forth in this Agreement, (iv) the Underwriters and their respective
affiliates may be engaged in a broad range of transactions that involve interests that differ from
those of the Company, and (v) the Underwriters have not provided any legal, accounting, regulatory
or tax advice with respect to the offering contemplated hereby and the Company has consulted its
own legal, accounting, regulatory and tax advisors to the extent it deemed appropriate.
SECTION 4. Payment of Expenses.
(a) Expenses. The Company will pay all expenses incident to the performance of its
obligations under this Agreement, including (i) the preparation, printing and filing of the
Registration Statement (including financial statements and any schedules or exhibits) as originally
filed and of each amendment thereto, (ii) the reproduction and delivery to the Underwriters of this
Agreement, any Agreement among Underwriters and such other documents as may be required in
connection with the offering, purchase, sale, issuance or delivery of the Securities, (iii) the
preparation, issuance and delivery of the certificates for the Securities to the Underwriters,
including any stock or other transfer taxes and any stamp or other duties payable upon the sale,
issuance or delivery of the Securities to be issued and sold by the Company to the Underwriters,
(iv) the fees and disbursements of the Company’s counsel, accountants and other advisors, (v) the
qualification of the Securities under securities laws in accordance with the provisions of Section
3(f) hereof, including filing fees and the reasonable fees and disbursements of counsel for the
Underwriters in connection therewith and in connection with the preparation of one Blue Sky Survey,
if any, and any supplement thereto for the Securities (provided that counsel fees in connection
therewith do not exceed $5,000), (vi) the printing and delivery to the Underwriters of copies of
each preliminary prospectus and of the Prospectus and any amendments or supplements thereto, (vii)
the fees and expenses of any transfer agent or registrar for the Securities, (viii) the costs and
expenses of the Company relating to investor presentations on any “road show” undertaken in
connection with the marketing of the Securities, including without limitation, expenses associated
with the production of road show slides and graphics, fees and expenses of any consultants engaged
in connection with the road show presentations, travel and lodging expenses of the representatives
and officers of the Company and any such consultants, and the cost of aircraft and other
transportation chartered in connection with the road show, (ix) the filing fees incident to, and
the reasonable fees and disbursements of counsel to the Underwriters in connection with, the review
by the National Association of Securities Dealers,
Inc. (the “NASD”) of the terms of the sale of the Securities, and (x) the fees and expenses
incurred in connection with the listing of the Securities on the New York Stock Exchange.
16
(b) Termination of Agreement. If this Agreement is terminated by the
Representatives in accordance with the provisions of Section 5 or Section 9(a)(i) hereof, the
Company shall reimburse the Underwriters for all of their out-of-pocket expenses, up to $200,000,
including the reasonable fees and disbursements of counsel for the Underwriters.
SECTION 5. Conditions of Underwriters’ Obligations. The obligations of the
several Underwriters hereunder are subject to the accuracy of the representations and warranties of
the Company contained in Section 1 hereof or in certificates of any officer of the Company or any
of its subsidiaries delivered pursuant to the provisions hereof, to the performance by the Company
of its covenants and other obligations hereunder, and to the following further conditions:
(a) Effectiveness of Registration Statement. The Registration Statement, including
the Rule 462(b) Registration Statement, has become effective and at Closing Time no stop order
suspending the effectiveness of the Registration Statement shall have been issued under the 1933
Act or proceedings therefor initiated or threatened by the Commission, and any request on the part
of the Commission for additional information shall have been complied with to the reasonable
satisfaction of counsel to the Underwriters. A prospectus supplement reflecting the terms of the
Securities, the terms of the offering thereof and the other matters set forth therein has been
prepared and will be filed pursuant to Rule 424 of the 1933 Act Regulations.
(b) Opinion of Counsel for Company. At Closing Time, the Representatives shall have
received the favorable opinion, dated as of Closing Time, in form and substance reasonably
satisfactory to counsel for the Underwriters, together with signed or reproduced copies of such
letter for each of the other Underwriters, of each of (i) Xxxxx & Lardner LLP, counsel for the
Company to the effect set forth in Exhibit A hereto; and (ii) Xxxxx X. XxXxxx, Vice President,
General Counsel and Corporate Secretary of the Company, to the effect set forth in Exhibit B
hereto.
(c) Opinion of Counsel for Underwriters. At Closing Time, the Representatives shall
have received the favorable opinion, dated as of Closing Time, of Xxxxxx & Xxxxxx L.L.P., counsel
for the Underwriters, together with signed or reproduced copies of such letter for each of the
other Underwriters with respect to the matters set forth in clauses (i), (iii), (v) through (ix),
inclusive and (x) (solely as to the information in the Prospectus under “Description of Capital
Stock—Common Stock”) and the penultimate paragraph of Exhibit A hereto. In giving such opinion
such counsel may rely, as to all matters governed by the laws of jurisdictions other than the
federal law of the United States and the General Corporation Law of the State of Delaware, upon the
opinions of counsel satisfactory to the Representatives. Such counsel may also state that, insofar
as such opinion involves factual matters, they have relied, to the extent they deem proper, upon
certificates of officers of the Company and its subsidiaries and certificates of public officials.
(d) Officers’ Certificate. At Closing Time, there shall not have been, since the
date hereof or since the respective dates as of which information is given in the Prospectus, any
material adverse change in the condition, financial or otherwise, or in the earnings, business
17
affairs or business prospects of the Company and its subsidiaries considered as one
enterprise, whether or not arising in the ordinary course of business, and the Representatives
shall have received a certificate of the President or a Vice President of the Company and of the
chief financial or chief accounting officer of the Company, dated as of Closing Time, to the effect
that (i) there has been no such material adverse change, (ii) the representations and warranties in
Section 1(a) hereof are true and correct with the same force and effect as though expressly made at
and as of Closing Time, (iii) the Company has complied in all material respects with all agreements
and satisfied all conditions on its part to be performed or satisfied at or prior to Closing Time,
and (iv) no stop order suspending the effectiveness of the Registration Statement has been issued
and no proceedings for that purpose have been instituted or are pending or, to their knowledge,
contemplated by the Commission.
(e) Accountant’s Comfort Letter. At the time of the execution of this Agreement,
the Representatives shall have received from Deloitte & Touche LLP a letter dated such date, in
form and substance satisfactory to the Representatives, together with signed or reproduced copies
of such letter for each of the other Underwriters containing statements and information of the type
ordinarily included in accountants’ “comfort letters” to underwriters with respect to the financial
statements and certain financial information contained in the Registration Statement and the
Prospectus.
(f) KPMG Comfort Letter. At the time of the execution of this Agreement, the
Representatives shall have received from KPMG LLP a letter dated such date, in form and substance
satisfactory to the Representatives, together with signed or reproduced copies of such letter for
each of the other Underwriters containing statements and information of the type ordinarily
included in accountants’ “comfort letters” to underwriters with respect to the financial statements
of Celero and certain financial information regarding Celero contained in the Registration
Statement and the Prospectus.
(g) Bring-down Comfort Letter. At Closing Time, the Representatives shall have
received from Deloitte & Touche LLP a letter, dated as of Closing Time, to the effect that they
reaffirm the statements made in the letter furnished pursuant to subsection (e) of this Section,
except that the specified date referred to shall be a date not more than three business days prior
to Closing Time.
(h) Approval of Listing. At Closing Time, the Securities shall have been approved
for listing on the New York Stock Exchange, subject only to official notice of issuance.
(i) No Objection. The NASD shall have confirmed that it has not raised any
objection with respect to the fairness and reasonableness of the underwriting terms and
arrangements.
(j) Lock-up Agreements. At the date of this Agreement, the Representatives shall
have received a lock-up agreement substantially in the form previously agreed to by the parties
hereto signed by the persons or entities listed on Schedule C hereto.
(k) Conditions to Purchase of Option Securities. In the event that the Underwriters
exercise their option provided in Section 2(b) hereof to purchase all or any portion of the Option
18
Securities, the representations and warranties of the Company contained herein and the
statements in any certificates furnished by the Company or any subsidiary of the Company hereunder
shall be true and correct as of each Date of Delivery and, at the relevant Date of Delivery, the
Representatives shall have received:
(i) Officers’ Certificate. A certificate, dated such Date of Delivery, of the
President or a Vice President of the Company and of the chief financial or chief accounting
officer of the Company confirming that the certificate delivered at the Closing Time
pursuant to Section 5(d) hereof remains true and correct as of such Date of Delivery.
(ii) Opinion of Counsel for Company. The favorable opinion of Xxxxx & Xxxxxxx
LLP, counsel for the Company, together with the favorable opinion of Xxxxx X. XxXxxx, Vice
President, General Counsel and Corporate Secretary of the Company, each in form and
substance reasonably satisfactory to counsel for the Underwriters, dated such Date of
Delivery, relating to the Option Securities to be purchased on such Date of Delivery and
otherwise to the same effect as the opinion required by Section 5(b) hereof.
(iii) Opinion of Counsel for Underwriters. The favorable opinion of Xxxxxx &
Xxxxxx L.L.P., counsel for the Underwriters, dated such Date of Delivery, relating to the
Option Securities to be purchased on such Date of Delivery and otherwise to the same effect
as the opinion required by Section 5(c) hereof.
(iv) Bring-down Comfort Letter. A letter from Deloitte & Touche LLP, in form
and substance satisfactory to the Representatives and dated such Date of Delivery,
substantially in the same form and substance as the letter furnished to the Representatives
pursuant to Section 5(g) hereof, except that the “specified date” in the letter furnished
pursuant to this paragraph shall be a date not more than five days prior to such Date of
Delivery.
(l) Additional Documents. At Closing Time and at each Date of Delivery, counsel for
the Underwriters shall have been furnished with such documents and opinions as they may reasonably
require for the purpose of enabling them to pass upon the issuance and sale of the Securities as
herein contemplated, or in order to evidence the accuracy of any of the representations or
warranties, or the fulfillment of any of the conditions, herein contained; and all proceedings
taken by the Company in connection with the issuance and sale of the Securities as herein
contemplated shall be reasonably satisfactory in form and substance to the Representatives and
counsel for the Underwriters.
(m) Termination of Agreement. If any condition specified in this Section shall not
have been fulfilled when and as required to be fulfilled, this Agreement, or, in the case of any
condition to the purchase of Option Securities, on a Date of Delivery which is after the Closing
Time, the obligations of the several Underwriters to purchase the relevant Option Securities, may
be terminated by the Representatives by notice to the Company at any time at or prior to Closing
Time or such Date of Delivery, as the case may be, and such termination shall be without liability
of any party to any other party except as provided in Section 4 and except that Sections 1, 6, 7
and 8 shall survive any such termination and remain in full force and effect.
19
SECTION 6. Indemnification.
(a) Indemnification of Underwriters. The Company agrees to indemnify and hold
harmless each Underwriter, its affiliates, as such term is defined in Rule 501(b) under the 1933
Act (each, an “Affiliate”) and each person, if any, who controls any Underwriter within the meaning
of Section 15 of the 1933 Act or Section 20 of the 1934 Act as follows:
(i) against any and all loss, liability, claim, damage and expense whatsoever, as
incurred, arising out of any untrue statement or alleged untrue statement of a material fact
contained in the Registration Statement (or any amendment thereto) or the omission or
alleged omission therefrom of a material fact required to be stated therein or necessary to
make the statements therein not misleading or arising out of any untrue statement or alleged
untrue statement of a material fact included in any preliminary prospectus or the Prospectus
(or any amendment or supplement thereto), or the omission or alleged omission therefrom of a
material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading;
(ii) against any and all loss, liability, claim, damage and expense whatsoever, as
incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any
investigation or proceeding by any governmental agency or body, commenced or threatened, or
of any claim whatsoever based upon any such untrue statement or omission, or any such
alleged untrue statement or omission; provided that (subject to Section 6(d) below) any such
settlement is effected with the written consent of the Company; and
(iii) against any and all expense whatsoever, as incurred (including the fees and
disbursements of counsel chosen by the Representatives), reasonably incurred in
investigating, preparing or defending against any litigation, or any investigation or
proceeding by any governmental agency or body, commenced or threatened, or any claim
whatsoever based upon any such untrue statement or omission, or any such alleged untrue
statement or omission, to the extent that any such expense is not paid under (i) or (ii)
above;
provided, however, that this indemnity agreement shall not apply to any loss,
liability, claim, damage or expense to the extent arising out of any untrue statement or omission
or alleged untrue statement or omission made in reliance upon and in conformity with written
information furnished to the Company by any Underwriter through the Representatives expressly for
use in the Registration Statement (or any amendment thereto), including any preliminary prospectus
or the Prospectus (or any amendment or supplement thereto); provided, further, that this
indemnity agreement shall not inure to the benefit of any Underwriter or any person who controls
such Underwriter on account of any such loss, liability, claim, damage or expense arising out of
any such defect or alleged defect in any preliminary prospectus if a copy of the Prospectus shall
not have been given or sent by such Underwriter with or prior to the written confirmation of the
sale involved to the extent that (i) the Prospectus would have cured such defect or alleged defect
and (ii) sufficient quantities of the Prospectus were timely made available to such Underwriter.
20
(b) Indemnification of Company. Each Underwriter severally agrees to indemnify and
hold harmless the Company, its directors, each of its officers who signed the Registration
Statement, and each person, if any, who controls the Company within the meaning of Section 15 of
the 1933 Act or Section 20 of the 1934 Act against any and all loss, liability, claim, damage and
expense described in the indemnity contained in Subsection (a)(1) of this Section 6, as incurred,
but only with respect to untrue statements or omissions, or alleged untrue statements or omissions,
made in the Registration Statement (or any amendment thereto), or any preliminary prospectus or the
Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with written
information furnished to the Company by such Underwriter through the Representatives expressly for
use in the Registration Statement (or any amendment thereto) or such preliminary prospectus or the
Prospectus (or any amendment or supplement thereto).
(c) Actions against Parties; Notification. Each indemnified party shall give notice
as promptly as reasonably practicable to each indemnifying party of any action commenced against it
in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying
party shall not relieve such indemnifying party from any liability hereunder to the extent it is
not materially prejudiced as a result thereof and in any event shall not relieve it from any
liability which it may have otherwise than on account of this indemnity agreement. In the case of
parties indemnified pursuant to Section 6(a)(1) above, counsel to the indemnified parties shall be
selected by Xxxxxxx Xxxxx, and, in the case of parties indemnified pursuant to Section 6(b) above,
counsel to the indemnified parties shall be selected by the Company. An indemnifying party may
participate at its own expense in the defense of any such action; provided,
however, that counsel to the indemnifying party shall not (except with the consent of the
indemnified party) also be counsel to the indemnified party. In no event shall the indemnifying
parties be liable for fees and expenses of more than one counsel (in addition to any local counsel)
separate from their own counsel for all indemnified parties in connection with any one action or
separate but similar or related actions in the same jurisdiction arising out of the same general
allegations or circumstances. In addition, the indemnifying party shall be entitled, to the extent
that it wishes, jointly with any other similarly notified indemnifying party, to assume the defense
of any claim or action brought against an indemnified party with counsel reasonably satisfactory to
the indemnified party. After notice from the indemnifying party to the indemnified party of its
election to assume the defense of such claim or action, the indemnifying party shall not be liable
to the indemnified party under this Section 6 for any legal or other expenses subsequently incurred
by the indemnified party in connection with the defense thereof other than reasonable costs of
investigation; provided, however, that the Representatives shall have the right to employ one
counsel (in addition to local counsel) to represent them and those other Underwriters and their
respective officers, employees and controlling persons who may be subject to liability arising out
of any claim in respect of which indemnity may be sought by the Underwriters against the
indemnifying party under this Section 6 if, in the reasonable judgment of the Representatives,
either (i) there is an actual or potential conflict between the position of the indemnifying party
on the one hand and the Underwriters on the other hand or (ii) there may be defenses available to
it or them that are different from or additional to those available to the indemnifying party (in
any of which events the indemnifying party shall not have the right to direct the defense of such
action on behalf of the Representatives with respect to such different defenses), in any of which
events such reasonable fees and expenses shall be borne by the indemnifying party. No indemnifying
party shall, without the prior written consent of the indemnified parties, settle or compromise or
consent to the entry of any judgment with respect to
21
any litigation, or any investigation or proceeding by any governmental agency or body,
commenced or threatened, or any claim whatsoever in respect of which indemnification or
contribution could be sought under this Section 6 or Section 7 hereof (whether or not the
indemnified parties are actual or potential parties thereto), unless such settlement, compromise or
consent (i) includes an unconditional release of each indemnified party from all liability arising
out of such litigation, investigation, proceeding or claim and (ii) does not include a statement as
to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified
party.
(d) Settlement without Consent if Failure to Reimburse. If at any time an
indemnified party shall have requested an indemnifying party to reimburse the indemnified party for
fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any
settlement of the nature contemplated by Section 6(a)(ii) effected without its written consent if
(i) such settlement is entered into more than 45 days after receipt by such indemnifying party of
the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such
settlement at least 30 days prior to such settlement being entered into and (iii) such indemnifying
party shall not have reimbursed such indemnified party in accordance with such request prior to the
date of such settlement.
SECTION 7. Contribution. If the indemnification provided for in Section 6
hereof is for any reason unavailable to or insufficient to hold harmless an indemnified party in
respect of any losses, liabilities, claims, damages or expenses referred to therein, then each
indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims,
damages and expenses incurred by such indemnified party, as incurred, (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company on the one hand and the
Underwriters on the other hand from the offering of the Securities pursuant to this Agreement or
(ii) if the allocation provided by clause (i) is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)
above but also the relative fault of the Company on the one hand and of the Underwriters on the
other hand in connection with the statements or omissions, which resulted in such losses,
liabilities, claims, damages or expenses, as well as any other relevant equitable considerations.
The relative benefits received by the Company on the one hand and the Underwriters on the
other hand in connection with the offering of the Securities pursuant to this Agreement shall be
deemed to be in the same respective proportions as the total net proceeds from the offering of the
Securities pursuant to this Agreement (before deducting expenses) received by the Company and the
total underwriting discount received by the Underwriters, in each case as set forth on the cover of
the Prospectus, bear to the aggregate initial public offering price of the Securities as set forth
on the cover of the Prospectus.
The relative fault of the Company on the one hand and the Underwriters on the other hand shall
be determined by reference to, among other things, whether any such untrue or alleged untrue
statement of a material fact or omission or alleged omission to state a material fact relates to
information supplied by the Company or by the Underwriters and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission.
22
The Company and the Underwriters agree that it would not be just and equitable if contribution
pursuant to this Section 7 were determined by pro rata allocation (even if the Underwriters were
treated as one entity for such purpose) or by any other method of allocation which does not take
account of the equitable considerations referred to above in this Section 7. The aggregate amount
of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred
to above in this Section 7 shall be deemed to include any legal or other expenses reasonably
incurred by such indemnified party in investigating, preparing or defending against any litigation,
or any investigation or proceeding by any governmental agency or body, commenced or threatened, or
any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged
omission.
Notwithstanding the provisions of this Section 7, no Underwriter shall be required to
contribute any amount in excess of the amount by which the total price at which the Securities
underwritten by it and distributed to the public were offered to the public exceeds the amount of
any damages which such Underwriter has otherwise been required to pay by reason of any such untrue
or alleged untrue statement or omission or alleged omission.
No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
0000 Xxx) shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation.
For purposes of this Section 7, each person, if any, who controls an Underwriter within the
meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act and each Underwriter’s
Affiliates and selling agents shall have the same rights to contribution as such Underwriter, and
each director of the Company, each officer of the Company who signed the Registration Statement,
and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act
or Section 20 of the 1934 Act shall have the same rights to contribution as the Company. The
Underwriters’ respective obligations to contribute pursuant to this Section 7 are several in
proportion to the number of Initial Securities set forth opposite their respective names in
Schedule A hereto and not joint.
SECTION 8. Representations, Warranties and Agreements to Survive. All
representations, warranties and agreements contained in this Agreement or in certificates of
officers of the Company or any of its subsidiaries submitted pursuant hereto, shall remain
operative and in full force and effect regardless of (i) any investigation made by or on behalf of
any Underwriter or its Affiliates or selling agents, any person controlling any Underwriter, its
officers or directors or any person controlling the Company and (ii) delivery of and payment for
the Securities.
SECTION 9. Termination of Agreement.
(a) Termination; General. The Representatives may terminate this Agreement, by
notice to the Company, at any time at or prior to Closing Time (i) if there has been, since the
time of execution of this Agreement or since the respective dates as of which information is given
in the Prospectus (exclusive of any amendment or supplement thereto subsequent to the date of this
Agreement), any material adverse change in the condition, financial or otherwise, or in the
earnings, business affairs or business prospects of the Company and its subsidiaries
23
considered as one enterprise, whether or not arising in the ordinary course of business, or
(ii) if there has occurred after the date hereof and prior to the Closing Time any material adverse
change in the financial markets in the United States or the international financial markets, any
outbreak of hostilities or escalation thereof or other calamity or crisis or any change or
development involving a prospective change in national or international political, financial or
economic conditions, in each case the effect of which is such as to make it, in the reasonable
judgment of the Representatives, impracticable or inadvisable to market the Securities or to
enforce contracts for the sale of the Securities, or (iii) if trading in any securities of the
Company has been suspended or materially limited by the Commission or the New York Stock Exchange,
or if trading generally on the American Stock Exchange or the New York Stock Exchange or in the
Nasdaq National Market has been suspended or materially limited, or minimum or maximum prices for
trading have been fixed, or maximum ranges for prices have been required, by any of said exchanges
or by such system or by order of the Commission, the NASD or any other governmental authority, or
(iv) if a material disruption has occurred in commercial banking or securities settlement or
clearance services in the United States, or (v) if a banking moratorium has been declared by either
federal or New York authorities.
(b) Liabilities. If this Agreement is terminated pursuant to this Section, such
termination shall be without liability of any party to any other party except as provided in
Section 4 hereof, and provided further that Sections 1, 6, 7 and 8 shall survive such termination
and remain in full force and effect.
SECTION 10. Default by One or More of the Underwriters. If one or more of
the Underwriters shall fail at Closing Time or a Date of Delivery to purchase the Securities which
it or they are obligated to purchase under this Agreement (the “Defaulted Securities”), the
Representatives shall have the right, within 24 hours thereafter, to make arrangements for one or
more of the non-defaulting Underwriters, or any other underwriters, to purchase all, but not less
than all, of the Defaulted Securities in such amounts as may be agreed upon and upon the terms
herein set forth; if, however, the Representatives shall not have completed such arrangements
within such 24-hour period, then:
(a) if the number of Defaulted Securities does not exceed 10% of the number of
Securities to be purchased on such date, each of the non-defaulting Underwriters shall be
obligated, severally and not jointly, to purchase the full amount thereof in the proportions
that their respective underwriting obligations hereunder bear to the underwriting
obligations of all non-defaulting Underwriters, or
(b) if the number of Defaulted Securities exceeds 10% of the number of Securities to be
purchased on such date, this Agreement or, with respect to any Date of Delivery which occurs
after the Closing Time, the obligation of the Underwriters to purchase and of the Company to
sell the Option Securities to be purchased and sold on such Date of Delivery shall terminate
without liability on the part of any non-defaulting Underwriter.
No action taken pursuant to this Section shall relieve any defaulting Underwriter from
liability in respect of its default.
24
In the event of any such default which does not result in a termination of this Agreement or,
in the case of a Date of Delivery which is after the Closing Time, which does not result in a
termination of the obligation of the Underwriters to purchase and the Company to sell the relevant
Option Securities, as the case may be, either the Representatives or the Company shall have the
right to postpone Closing Time or the relevant Date of Delivery, as the case may be, for a period
not exceeding seven days in order to effect any required changes in the Registration Statement or
Prospectus or in any other documents or arrangements. As used herein, the term “Underwriter”
includes any person substituted for an Underwriter under this Section 10.
SECTION 11. Tax Disclosure. Notwithstanding any other provision of this
Agreement, immediately upon commencement of discussions with respect to the transactions
contemplated hereby, the Company (and each employee, representative or other agent of the Company)
may disclose to any and all persons, without limitation of any kind, the tax treatment and tax
structure of the transactions contemplated by this Agreement and all materials of any kind
(including opinions or other tax analyses) that are provided to the Company relating to such tax
treatment and tax structure. For purposes of the foregoing, the term “tax treatment” is the
purported or claimed federal income tax treatment of the transactions contemplated hereby, and the
term “tax structure” includes any fact that may be relevant to understanding the purported or
claimed federal income tax treatment of the transactions contemplated hereby.
SECTION 12. Notices. All notices and other communications hereunder shall
be in writing and shall be deemed to have been duly given if mailed or transmitted by any standard
form of telecommunication. Notices to the Underwriters shall be directed to the Representatives at
1 Houston Center, 0000 XxXxxxxx Xxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxx 00000, attention of Xxxxx Xxxx;
notices to the Company shall be directed to them at 0000 Xxxxxxxx, Xxxxx 0000, Xxxxxx, Xxxxxxxx
00000-0000, attention of Xxxxx X. Xxxxxx.
SECTION 13. Parties. This Agreement shall inure to the benefit of and be
binding upon the Underwriters and the Company and their respective successors. Nothing expressed
or mentioned in this Agreement is intended or shall be construed to give any person, firm or
corporation, other than the Underwriters and the Company and their respective successors and the
controlling persons and officers and directors referred to in Sections 6 and 7 and their heirs and
legal representatives, any legal or equitable right, remedy or claim under or in respect of this
Agreement or any provision herein contained. This Agreement and all conditions and provisions
hereof are intended to be for the sole and exclusive benefit of the Underwriters and the Company
and their respective successors, and said controlling persons and officers and directors and their
heirs and legal representatives, and for the benefit of no other person, firm or corporation. No
purchaser of Securities from any Underwriter shall be deemed to be a successor by reason merely of
such purchase.
SECTION 14. GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.
SECTION 15. TIME. TIME SHALL BE OF THE ESSENCE OF THIS AGREEMENT. EXCEPT AS
OTHERWISE SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME.
25
SECTION 16. Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be deemed to be an original, but all such counterparts shall
together constitute one and the same Agreement.
SECTION 17. Effect of Headings. The Section headings herein are for
convenience only and shall not affect the construction hereof.
26
If the foregoing is in accordance with your understanding of our agreement, please sign and
return to the Company a counterpart hereof, whereupon this instrument, along with all counterparts,
will become a binding agreement between the Underwriters and the Company in accordance with its
terms.
Very truly yours, XXXXXXX PETROLEUM CORPORATION |
||||
By | /s/ Xxxxx X. Xxxxxx | |||
Title: Chairman and Chief Executive Officer | ||||
CONFIRMED AND ACCEPTED,
as of the date first above written:
as of the date first above written:
XXXXXXX XXXXX & CO.
XXXXXXX LYNCH, PIERCE, XXXXXX & XXXXX
INCORPORATED
X.X. XXXXXX SECURITIES INC.
WACHOVIA CAPITAL MARKETS, LLC
BANC OF AMERICA SECURITIES LLC
XXXXXX BROTHERS INC.
KEYBANC CAPITAL MARKETS,
A DIVISION OF MCDONALD INVESTMENTS, INC.
XXXXXXX XXXXX & ASSOCIATES, INC.
XXXXXX XXXXXXX & CO., INC.
RBC CAPITAL MARKETS CORPORATION
XXXXXXX & COMPANY INTERNATIONAL
XXXXXXX LYNCH, PIERCE, XXXXXX & XXXXX
INCORPORATED
X.X. XXXXXX SECURITIES INC.
WACHOVIA CAPITAL MARKETS, LLC
BANC OF AMERICA SECURITIES LLC
XXXXXX BROTHERS INC.
KEYBANC CAPITAL MARKETS,
A DIVISION OF MCDONALD INVESTMENTS, INC.
XXXXXXX XXXXX & ASSOCIATES, INC.
XXXXXX XXXXXXX & CO., INC.
RBC CAPITAL MARKETS CORPORATION
XXXXXXX & COMPANY INTERNATIONAL
By: | XXXXXXX LYNCH, PIERCE, XXXXXX & XXXXX INCORPORATED |
By: | /s/ Xxxxxx X. Xxxxx, Xx. Authorized Signatory |
By: | X.X. XXXXXX SECURITIES INC. |
By: | /s/ Xxx Xxxxxxx-Xxxxx Vice President |
27
By: | WACHOVIA CAPITAL MARKETS, LLC |
By: | /s/ Xxxx Xxxxxx Authorized Signatory |
For themselves and as Representatives of each of the other Underwriters named in Schedule A
hereto.
28
SCHEDULE A
Number of | ||||
Initial | ||||
Name of Underwriter | Securities | |||
Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated |
1,725,000 | |||
X.X. Xxxxxx Securities Inc. |
1,293,750 | |||
Wachovia Capital Markets, LLC |
632,500 | |||
Banc of America Securities LLC |
575,000 | |||
Xxxxxx Brothers Inc. |
575,000 | |||
KeyBanc Capital Markets, a Division of McDonald Investments Inc. |
402,500 | |||
Xxxxxxx Xxxxx & Associates, Inc. |
316,250 | |||
Xxxxxx Xxxxxxx & Co., Inc. |
115,000 | |||
RBC Capital Markets Corporation |
57,500 | |||
Xxxxxxx & Company International |
57,500 | |||
Total |
5,750,000 | |||
A-1